Molecular Cancer (Mar 2023)
Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer
- Zhuo-yuan Lin,
- Guo Chen,
- Yan-qiong Zhang,
- Hui-chan He,
- Yu-xiang Liang,
- Jian-heng Ye,
- Ying-ke Liang,
- Ru-jun Mo,
- Jian-ming Lu,
- Yang-jia Zhuo,
- Yu Zheng,
- Fu-neng Jiang,
- Zhao-dong Han,
- Shu-lin Wu,
- Wei-de Zhong,
- Chin-Lee Wu
Affiliations
- Zhuo-yuan Lin
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular, Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou, Medical University
- Guo Chen
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular, Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou, Medical University
- Yan-qiong Zhang
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
- Hui-chan He
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular, Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou, Medical University
- Yu-xiang Liang
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular, Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou, Medical University
- Jian-heng Ye
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular, Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou, Medical University
- Ying-ke Liang
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular, Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou, Medical University
- Ru-jun Mo
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular, Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou, Medical University
- Jian-ming Lu
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular, Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou, Medical University
- Yang-jia Zhuo
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular, Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou, Medical University
- Yu Zheng
- Department of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Medical University
- Fu-neng Jiang
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular, Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou, Medical University
- Zhao-dong Han
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular, Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou, Medical University
- Shu-lin Wu
- Department of Pathology, Massachusetts General Hospital and Harvard, Medical School
- Wei-de Zhong
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular, Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou, Medical University
- Chin-Lee Wu
- Department of Urology, Guangdong Key Laboratory of Clinical Molecular, Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou, Medical University
- DOI
- https://doi.org/10.1186/s12943-023-01763-5
- Journal volume & issue
-
Vol. 22,
no. 1
pp. 1 – 1
Abstract
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12943-017-0615-x.
